Facilitated By

San Antonio Medical Foundation

A MULTICENTER, RANDOMIZED, BLINDED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY OF MARAVIROC IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS IN HIV-1-INFECTED SUBJECTS CO-INFECTED WITH HEPATITIS C AND/OR HEPATITIS B VIRUS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Anstead,Gregory M
Funded by
PFIZER
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Infectious Disease